CRSP Net Change in Cash
Crispr Therapeutics Ag · Net Change in Cash
CRSP Net Change in Cash
Latest reported-$131.97Mperiod ending
CRSP Quarterly Net Change in Cash ($3.68M → -$131.97M)
Quarterly net change in cash
High-resolution chart · PNG
CRSP net change in cash history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Change in Cash (USD) |
|---|---|
| -131,971,000 | |
| 68,520,000 | |
| 61,061,000 | |
| 92,879,000 | |
| -41,565,000 | |
| -63,073,000 | |
| 72,586,000 | |
| -258,802,000 | |
| -222,951,000 | |
| 317,875,000 | |
| -138,288,000 | |
| 82,969,000 | |
| 100,389,000 | |
| 132,522,000 | |
| -282,266,000 | |
| -2,742,000 | |
| -187,743,000 | |
| -239,125,000 | |
| -88,517,000 | |
| -635,098,000 | |
| 521,814,000 | |
| -42,565,000 | |
| 127,206,000 | |
| 106,891,000 | |
| 56,618,000 | |
| -54,059,000 | |
| 315,180,000 | |
| 201,832,000 | |
| -8,912,000 | |
| -19,100,000 | |
| -30,648,000 | |
| 167,558,000 | |
| -22,030,000 | |
| 102,020,000 | |
| -13,761,000 | |
| -18,745,000 | |
| -16,608,000 | |
| -26,648,000 | |
| 86,907,000 | |
| -18,236,000 | |
| 46,249,000 | |
| 44,639,000 | |
| 106,912,000 | |
| -5,622,000 | |
| 50,043,000 | |
| 3,683,000 |